Drug Profile
Teroxirone
Alternative Names: alpha-TGT; L-TGI; NSC 296934; TGTLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Henkel
- Developer Degussa; Henkel
- Class Antineoplastics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 22 Feb 1995 Discontinued-I for Cancer in USA (IV)